Preclinical development of a bispecific antibody that safely and effectively targets CD19 and CD47 for the treatment of B cell lymphoma and leukemia

CD47, a ubiquitously expressed innate immune checkpoint receptor that serves as a universal “don’t eat me” signal of phagocytosis, is often up-regulated by hematological and solid cancers to evade immune surveillance. Development of CD47-targeted modalities is hindered by the ubiquitous expression o...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Mol Cancer Ther
Główni autorzy: Buatois, Vanessa, Johnson, Zoë, Pires, Susana Salgado, Papaioannou, Anne, Hatterer, Eric, Chauchet, Xavier, Richard, Françoise, Barba, Leticia, Daubeuf, Bruno, Cons, Laura, Broyer, Lucile, D’Asaro, Matilde, Matthes, Thomas, LeGallou, Simon, Fest, Thierry, Tarte, Karin, Hinojosa, Robert K. Clarke, Ferrer, Eulàlia Genescà, Ribera, José María, Dey, Aditi, Bailey, Katharine, Fielding, Adele K., Eissenberg, Linda, Ritchey, Julie, Rettig, Michael, DiPersio, John F., Kosco-Vilbois, Marie H., Masternak, Krzysztof, Fischer, Nicolas, Shang, Limin, Ferlin, Walter G.
Format: Artigo
Język:Inglês
Wydane: 2018
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6072583/
https://ncbi.nlm.nih.gov/pubmed/29743205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-17-1095
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy